Potential anti‐SARS‐CoV‐2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease-Reference-Cited by-同舟云学术

Potential anti‐SARS‐CoV‐2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease

Published:2020-05-29 Issue:6 Volume:10 Page:995-1004
ISSN:2211-5463
Container-title:FEBS Open Bio
language:en
Short-container-title:FEBS Open Bio

Author:

Tsuji Motonori¹^ORCID

Affiliation:

1. Institute of Molecular Function Misato‐shi, Saitama Japan

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/2211-5463.12875

Reference22 articles.

1. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

2. X‐ray structure of main protease of the novel coronavirus SARS‐CoV‐2 enables design of α‐ketoamide inhibitors;Zhang L;bioRxiv,2020

3. Structure of Mpro from COVID‐19 virus and discovery of its inhibitors;Jin Z;bioRxiv,2020

4. ChEMBL web services: streamlining access to drug discovery data and utilities

5. Development of the structure‐based drug design systems, HMHC and DSHC;Tsuji M;Mol Sci,2007

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin as a natural potential drug candidate against important zoonotic viruses and prions: A narrative review;Phytotherapy Research;2024-04-12

2. Computer Aided Structure-Based Drug Design of Novel SARS-CoV-2 Main Protease Inhibitors: Molecular Docking and Molecular Dynamics Study;Computation;2024-01-20

3. A review on in silico virtual screening methods in COVID-19 using anticancer drugs and other natural/chemical inhibitors;Exploration of Targeted Anti-tumor Therapy;2023-10-26

4. Diarylpentanoids, the privileged scaffolds in antimalarial and anti‐infectives drug discovery: A review;Archiv der Pharmazie;2023-10-08

5. Bio-activity prediction of drug candidate compounds targeting SARS-Cov-2 using machine learning approaches;PLOS ONE;2023-09-05